NCT03492489 Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma Status NO_LONGER_AVAILABLE Phase N/A
NCT03485677 Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3 Status COMPLETED Phase PHASE3
NCT03463135 A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients Status COMPLETED Phase PHASE1
NCT03462069 Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate Hypertension Status COMPLETED Phase PHASE2
NCT03462017 Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT03449758 Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT03439943 Study to Evaluate the Effect of Lixisenatide in Patient With Parkinson's Disease Status COMPLETED Phase PHASE2
NCT03437720 Assessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver Disease Status WITHDRAWN Phase PHASE2
NCT03436498 Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients Status COMPLETED Phase PHASE1
NCT03434119 Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents Status TERMINATED Phase PHASE3
NCT03430063 A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer Status TERMINATED Phase PHASE2
NCT03428646 Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03415269 A Study of the Effect of 20 mg Ambroxol Hydrochloride on Acute Cough. Status COMPLETED Phase PHASE2
NCT03415178 Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy Status COMPLETED Phase PHASE3
NCT03414736 A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period Status COMPLETED Phase PHASE1
NCT03414723 A Drug-Drug Interaction Study Between Sotagliflozin and Ramipril Status COMPLETED Phase PHASE1
NCT03409614 Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer Status COMPLETED Phase PHASE3
NCT03406663 The Korean TITRATION Study: Comparison of the Self-titration Methods for Glargine-300 Status COMPLETED Phase NA
NCT03406000 Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mL Status COMPLETED Phase PHASE4